Skip to product information
1 of 1

Coenzyme / cellular-metabolism research compound

NAD+ Research Pen

NAD+ Research Pen

NAD+ (oxidized nicotinamide adenine dinucleotide; nadide)

Regular price Dhs. 0.00 AED
Regular price Sale price Dhs. 0.00 AED
Sale Sold out
Strength
Quantity

NAD+ is an oxidized dinucleotide coenzyme used in biochemical research on cellular redox reactions, energy metabolism and NAD-dependent enzyme systems, supplied as a 3 mL pre-filled research pen containing 1000 mg total.

Specifications

Active material
NAD+ (oxidized nicotinamide adenine dinucleotide; nadide)
Declared presentation
1000 mg total per pen
Container
3 mL nominal cartridge, one pre-filled pre-mixed pen
Nominal concentration
333.33 mg/mL nominal (1000 mg / 3 mL)
CAS number(s)
53-84-9 for parent NAD+
Molecular formula
C21H27N7O14P2
Molecular weight
663.43 g/mol
Sequence / structure
Not applicable — NAD+ is a dinucleotide coenzyme
Synonyms
Nadide; beta-nicotinamide adenine dinucleotide, oxidized form

What this material is studied for

  • NAD+/NADH redox-cycle and oxidoreductase assays.
  • Sirtuin, PARP, CD38 and other NAD-consuming enzyme research.
  • Cellular energetics, mitochondrial metabolism and stress-response models.

Scientific context

NAD+ participates in oxidation-reduction reactions by accepting electrons to form NADH. It also serves as a substrate for NAD-consuming enzymes, including sirtuins, PARPs and CD38. Research applications include dehydrogenase assays, NAD+/NADH redox studies, cellular energetics, mitochondrial metabolism and enzyme-pathway experiments.

Storage and handling

Store a mixed or in-use research pen refrigerated at 2–8 °C (36–46 °F). Keep unused pens cold until their expiry date, protect them from direct light, and never freeze them.

Disclaimer

For laboratory research use only. Not for human or veterinary use. Not a food, drug, cosmetic or dietary supplement. Not intended to diagnose, treat, cure or prevent any disease. Purchasers are responsible for lawful handling and use by qualified personnel.

View full details